Literature DB >> 21126552

Non-specific binding and general cross-reactivity of Y receptor agonists are correlated and should importantly depend on their acidic sectors.

M S Parker1, R Sah, A Balasubramaniam, F R Sallee, O Zerbe, S L Parker.   

Abstract

Non-specific binding of Y receptor agonists to intact CHO cells, and to CHO cell or rat brain particulates, is much greater for human neuropeptide Y (hNPY) compared to porcine peptide Y (pPYY), and especially relative to human pancreatic polypeptide (hPP). This binding of hNPY is reduced by alkali cations in preference to non-ionic chaotrope urea, while the much lower non-specific binding of pPYY is more sensitive to urea. The difference could mainly be due to the 10-16 stretch in 36-residue Y agonists (residues 8-14 in N-terminally clipped 34-peptides), located in the sector that contains all acidic residues of physiological Y agonists. Anionic pairs containing aspartate in the 10-16 zone could be principally responsible for non-specific attachments, but may also aid the receptor site binding. Two such pairs are found in hNPY, one in pPYY, and none in hPP. The hydroxyl amino acid residue at position 13 in mammalian PYY and PP molecules could lower conformational plasticity and the non-selective binding via intrachain hydrogen bonding. The acidity of this tract could also be important in agonist selectivity of the Y receptor subtypes. The differences point to an evolutionary reduction of promiscuous protein binding from NPY to PP, and should also be important for Y agonist selectivity within NPY receptor group, and correlate with partial agonism and out-of group cross-reactivity with other receptors. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21126552      PMCID: PMC3025077          DOI: 10.1016/j.peptides.2010.11.018

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  60 in total

1.  Ser and Thr residues modulate the conformation of pro-kinked transmembrane alpha-helices.

Authors:  Xavier Deupi; Mireia Olivella; Cedric Govaerts; Juan Antonio Ballesteros; Mercedes Campillo; Leonardo Pardo
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

2.  Porter: a new, accurate server for protein secondary structure prediction.

Authors:  Gianluca Pollastri; Aoife McLysaght
Journal:  Bioinformatics       Date:  2004-12-07       Impact factor: 6.937

3.  Dimers of the neuropeptide Y (NPY) Y2 receptor show asymmetry in agonist affinity and association with G proteins.

Authors:  M S Parker; R Sah; A Balasubramaniam; F R Sallee; T Sweatman; E A Park; S L Parker
Journal:  J Recept Signal Transduct Res       Date:  2008       Impact factor: 2.092

4.  Neuropeptide Y as a partial agonist of the Y1 receptor.

Authors:  Renu Sah; Ambikaipakan Balasubramaniam; Michael S Parker; Floyd Sallee; Steven L Parker
Journal:  Eur J Pharmacol       Date:  2005-11-15       Impact factor: 4.432

5.  [Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist.

Authors:  J Fuhlendorff; U Gether; L Aakerlund; N Langeland-Johansen; H Thøgersen; S G Melberg; U B Olsen; O Thastrup; T W Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

6.  Characterization of the receptors for peptide-YY and avian pancreatic polypeptide in chicken and pig brains.

Authors:  A Inui; M Okita; M Miura; Y Hirosue; M Nakajima; T Inoue; M Oya; S Baba
Journal:  Endocrinology       Date:  1990-08       Impact factor: 4.736

7.  Modeling the G-protein-coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites.

Authors:  P Du; J A Salon; J A Tamm; C Hou; W Cui; M W Walker; N Adham; D S Dhanoa; I Islam; P J Vaysse; B Dowling; Y Shifman; N Boyle; H Rueger; T Schmidlin; Y Yamaguchi; T A Branchek; R L Weinshank; C Gluchowski
Journal:  Protein Eng       Date:  1997-02

8.  Sensitivity of orexin-A binding to phospholipase C inhibitors, neuropeptide Y, and secretin.

Authors:  J K Kane; H Tanaka; S L Parker; M Yanagisawa; M D Li
Journal:  Biochem Biophys Res Commun       Date:  2000-06-16       Impact factor: 3.575

9.  Probing the formation of stable tertiary structure in a model miniprotein at atomic resolution: determinants of stability of a helical hairpin.

Authors:  Alexey Neumoin; Jiri Mares; Mirjam Lerch-Bader; Reto Bader; Oliver Zerbe
Journal:  J Am Chem Soc       Date:  2007-06-20       Impact factor: 15.419

10.  Structure-activity relationship of novel pentapeptide neuropeptide Y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding.

Authors:  A J Daniels; J E Matthews; O H Viveros; J J Leban; M Cory; D Heyer
Journal:  Mol Pharmacol       Date:  1995-09       Impact factor: 4.436

View more
  2 in total

Review 1.  Immunomodulatory Role of Neuropeptides in the Cornea.

Authors:  Sudan Puri; Brendan M Kenyon; Pedram Hamrah
Journal:  Biomedicines       Date:  2022-08-16

2.  Neuropeptide Y receptors: how to get subtype selectivity.

Authors:  Xavier Pedragosa-Badia; Jan Stichel; Annette G Beck-Sickinger
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-04       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.